chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sneezing a lot; Woke up tired; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing a lot) and FATIGUE (Woke up tired) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concurrent medical conditions included Down's syndrome.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced SNEEZING (Sneezing a lot) and FATIGUE (Woke up tired). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SNEEZING (Sneezing a lot) and FATIGUE (Woke up tired) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Event outcome updated.
Patient presents to ED for evaluation of suspected allergic reaction.  Patient was seen immediately upon arrival due to clinical status.  Hemodynamically stable with suspected allergic reaction secondary to Covid vaccine.  Patient was given Benadryl/Pepcid/prednisone.  Patient was observed in the ED for period of 2 hours with near complete resolution of symptoms.  Patient is comfortable with discharge home at this point.  Will give the patient prescription for Benadryl and EpiPen if needed.  Patient already has information for allergy/immunology and will follow up.  Results of diagnostic testing and preliminary diagnosis discussed with patient and family members (if present) at the bedside who expressed understanding and agreed the plan of care.  Patient will be discharged from the ER to follow up with primary care physician. The results of pertinent diagnostic studies and exam findings were discussed. The patient?s provisional diagnosis and plan of care were discussed with the patient and present family. Vitals are stable. Patient is alert and oriented, no acute distress and nontoxic appearing. Patient was given discharged instructions and all questions were answered. The patient and/or present family expressed understanding of the diagnosis and plan. The patient understands their need and responsibility to obtain additional follow-up as instructed. Strict return precautions were given to the patient. The risks of medications administered and prescribed were discussed with the patient and family present.
apr90 pt vax hepta B.  may90 pt vax 2nd hepta B. in 21jun90 while undergoing a routine physical lab eval. anti-HB's neg and HBsAg pos. pt med history - 3 surgery - recv massive transfusions. hepta profiles neg. for A nd B.
Vaccine expired on 12-Feb-2021/removed from freezer to thaw on 20-Mar-2023; No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vaccine expired on 12-Feb-2021/removed from freezer to thaw on 20-Mar-2023) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 015B22A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 20-Mar-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 12-Feb-2021/removed from freezer to thaw on 20-Mar-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vaccine expired on 12-Feb-2021/removed from freezer to thaw on 20-Mar-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Vaccine expired on 12-Feb-2021/removed from freezer to thaw on 20-Mar-2023).    No concomitant medications were reported.  It was unknown if the patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  The vial was removed from freezer to thaw 20-Mar-2023.  The vial did not undergo any temperature excursions.  The patient had shots around 8:30 this morning.  No side effects had been reported.   No treatment medications were reported.  This case contains information for the 2nd of 3 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-716275, US-MODERNATX, INC.-MOD-2023-716279 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716275:Patient 1 out of 3 Patients US-MODERNATX, INC.-MOD-2023-716279:Patient 3 out of 3 Patients
4/6 vaccination 4/12 HA 4/13 HA turned into migraine, legs started to tingle, achy. Zero sleep due to pain. 4/14 Both extremities very swollen. Rotating between Tylenol and Ibuprofen (started on Tues). I went to my PCM. BP 130/98. Prescribed water pill but only to take on Friday if symptoms got worse, not better.  4/15 Sick all day. By 5pm, I couldn't even focus, my legs were so swollen, my 'head was ready to explode' and I  'didn't feel right. I went to urgent care; 160/98 BP and referred to the ER. I went to the ER, BP was still elevated, legs still swollen. Checked my heart, ultra sound on my legs and x-ray. I was kind of 'out of it'. They did everything to check for blood clots and heart; everything came back clear. They gave me some medicine for my head thru IV. I still left with HA but didn't feel as bad. That helped my BP went down. I was at the ER 2-3 hours, drinking lots of water. The next day the swelling started to go down on the legs and migraine was subsided. By Sat., I felt fine.
Fever; tired; coughing; sore throat; This spontaneous case was reported by a pharmacist and describes the occurrence of COUGH (coughing), OROPHARYNGEAL PAIN (sore throat), PYREXIA (Fever) and FATIGUE (tired) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced COUGH (coughing) and OROPHARYNGEAL PAIN (sore throat). On 18-Mar-2021, the patient experienced PYREXIA (Fever). 18-Mar-2021, the patient experienced FATIGUE (tired). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 2 Motrin tablets about 12 hours after dose and another dose 4 hours later and third dose the next day. At the time of the report, COUGH (coughing), OROPHARYNGEAL PAIN (sore throat), PYREXIA (Fever) and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
On 7/6/06 client came to HD stating that on 11/08/05 he had a flu shot that resulted in many untoward side effects necessitating Dr visits and testing. S/s began 2 days after shot with night sweats and one-two wks later needed CXR and antibiotics for Dx of pneumonia or a spot on lung which he is still being followed up for and is scheduled for a CT of lungs. Also saw Dr for hearing loss and sinus problems. Had about 10 Dr visits since onset to date. Coughing resolved but lung spot remains for weeks. Still testing and follow up in process.
breathing issues/his breathing, it´s so bad, he can´t breath and it´s getting worse/couldn´t get his breathing right; minimum smell; minimum taste; freaking dying because of the vaccine; his legs will give up, so he has to lay down; he feels like he is going to pass out; all his face gets numb; he throws up; headaches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (breathing issues/his breathing, it´s so bad, he can´t breath and it´s getting worse/couldn´t get his breathing right), HYPOSMIA (minimum smell), HYPOGEUSIA (minimum taste), VACCINATION COMPLICATION (freaking dying because of the vaccine) and MUSCULAR WEAKNESS (his legs will give up, so he has to lay down) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Trobanil) and Asthma (didn´t bother him for years).    On 09-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (breathing issues/his breathing, it´s so bad, he can´t breath and it´s getting worse/couldn´t get his breathing right), HYPOSMIA (minimum smell), HYPOGEUSIA (minimum taste), VACCINATION COMPLICATION (freaking dying because of the vaccine), MUSCULAR WEAKNESS (his legs will give up, so he has to lay down), PRESYNCOPE (he feels like he is going to pass out), HYPOAESTHESIA (all his face gets numb), VOMITING (he throws up) and HEADACHE (headaches). At the time of the report, DYSPNOEA (breathing issues/his breathing, it´s so bad, he can´t breath and it´s getting worse/couldn´t get his breathing right), HYPOSMIA (minimum smell), HYPOGEUSIA (minimum taste), VACCINATION COMPLICATION (freaking dying because of the vaccine), MUSCULAR WEAKNESS (his legs will give up, so he has to lay down), PRESYNCOPE (he feels like he is going to pass out), HYPOAESTHESIA (all his face gets numb), VOMITING (he throws up) and HEADACHE (headaches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.         Patient reported his asthma had gotten worse. Patient stayed in the ER for a day because they could not get his breathing right. The patient went to the ER with Covid-19 symptoms and was tested for Covid-19 numerous times. Concomitant medications reported were Diabetes medicine, Blood pressure medicine, Heart medicine. Treatment included Breathing treatments, oxygen and other medications.   This case was linked to MOD-2022-516667, MOD-2022-516904 (Patient Link).
Pt vaccinated with MMR developed headache, face flushed, not feelling well, throat feeling tight & difficulty breathing.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 4/30/2023 Discharge Date: May 1, 2023  PRESENTING PROBLEM: Precordial chest pain [R07.2] Chest pain [R07.9] Essential hypertension [I10] Abnormal EKG [R94.31] COVID-19 [U07.1]   HOSPITAL COURSE: 71-year-old female with a past medical history significant for diabetes as well as contact with a family member with COVID-19 who presents due to complaints of headache, chest pain, shortness of breath.   In the emergency department the patient is tachycardic with otherwise stable.  EKG was obtained which showed some nonspecific ST-T changes.  Repeat EKG showed similar findings.  High sensitivity cardiac enzymes were tested and found to be in the indeterminate range with slight increased upon repeat check.  Patient was checked for COVID-19 and found to be positive.  D-dimer was found to be negative.  Chest x-ray showed no acute process.  Case was discussed with Cardiology patient was recommended to be admitted to the hospital with cardiology consultation.   Patient seen in consultation by Cardiology.  Cardiology recommended echocardiogram to ensure no evidence of cardiomyopathy.  Eventually, echocardiogram came back showing a preserved ejection fraction with no evidence of focal wall motion abnormality and no evidence of pericardial effusion.   Per Cardiology, there was no indication for any further testing from a cardiac standpoint.  Patient felt essentially unchanged from admission but she remained hemodynamically stable and on room air.  Patient inquired as to use of Paxlovid in the setting of acute COVID-19 infection.  Patient was prescribed Paxlovid and  discharged home in stable condition on 05/01.
cellulitis below the injection site that presented greater than 48 hours after the injection of the vaccine. (redness, induration, increased warmth, tender, swelling) Site marked with a marker and pt started on an antibiotic and antihistamine.  Cool compresses, rest, hydrate well.
Patient did not report any side effects after given the Pfizer adult vaccine on 11/13/2021. Patient is fine per care giver grandmother.
After booster/2nd shot was given. Patient was ill with shivers, locked up/ tight body. Was sick for day and a half..  Heart palpitations started within 1 week of booster. been ongoing ever since. Now feeling breathless, waking up in the morning with palpitations. Passing out randomly during daytime. Palpitations are worse when laying down
Vertigo, dizziness, headache, lightheaded, confusion Consulted with GP.  Referral to Neurologist.  Neurologist referred to Vestibular Rehabilitation.  Vestibular Rehab treatment still ongoing.  MRI completed
Information had been received on 19-JUL-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient of unknown age was inoculated with ZOSTAVAX vaccine (dose, route, site of administration, lot # and expiration date were not provided) on or about 26-MAR-2013 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. The lawyer reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of Herpes Zoster. On or about 02-APR-2016, the patient was treated at a medical center for a painful and blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. On or about 25-MAY-2016, the patient was treated by a physician at a clinic for continuing and worsening symptoms, which was then diagnosed as post herpetic neuralgia, a chronic condition of residual nerve damage and pain secondary to shingles. The patient was prescribed gabapentin and oxycodone to help curb her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a  further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
12/31 vaccination Later that afternoon, I started with body aches, hard time breathing. My husband took me to urgent care and put me on O2 for a while. A couple days later, same episode. Off and on, depending how active I was, it would happen. I would use my inhaler when needed. I went to talk to dr. Went back to urgent care . They got me a O2 machine and nebulizer. Stayed in at hotel and admitted into the hospital. I had to be incubated and inpatient till 1/29/ 2021. I was told I was COVID +. I really don't remember. I couldn't walk, move, I was too weak. I am still going thru physical therapy, appt to see lung doctor, on O2 machine. I go to PT 1x a week because I don't have enough oxygen bottles.  *PCM ordering CT and to see lung specialist ; putting in referral  *Referral OBGYN, stomach issues/pain *feet numbing and tingling; I still lose balance
Had shingles after having both Shingrex shots/Suspected vaccination failure; Had shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 3-Nov-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had shingles after having both Shingrix shots. The reporter did not consent to follow-up. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
I have sharp pain in my arm and shoulder. I had swelling over my eyes and around them. I have had a fast heart beat, muscle weakness fatigue and shakiness. I got examined at the doctor office. Was prescribed Naproxen 500MG but it does not help the pain I'm feeling.
Narrative: Patient received 1st dose of Moderna COVID-19 vaccine on 2/13/21. Patient then presented to the ED on 2/15/21 for chest pain and shortness of breath. In the ED, he was noted to be agitated and have altered mental status. He was intubated in the ED for airway protection and started on Propofol for sedation. Patient was also found to be hypervolemic on admission, consistent with heart failure exacerbation. During his hospitalization, he underwent diuresis, but also developed acute renal failure requiring hemodialysis x2, and continues to have persistent encephalopathy despite cessation of sedation on 2/23/21. Patient was also treated for cavitating pneumonia with 7 days of cefepime. He had a tracheostomy done on 3/1. He has not received his 2nd dose of the COVID-19 vaccine.
Chills; A spontaneous report was received from a consumer, concerning herself, a 75-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed chills.  The patient's medical history was not provided. Concomitant product use was not provided.  On 15 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot # unknown) in the left arm for prophylaxis of COVID-19 infection.   On 17 Jan 2021, after vaccine administration, since Sunday, the patient started experiencing chills. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event chill was considered not resolved at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Vasovagal syncope - We helped the patient to the floor at her request, gave her a pillow to lay her head on, gave her cold water to drink, and fanned her with a clip board. After about 10 minutes, she was able to get up and sit in a chair by herself. She looked a lot better and the color had retuned to her face. She mentioned that she has a phobia of needles, as well as anxiety disorder. She also mentioned that she has not eaten since lunchtime. We got her a candy bar at her request. We had her wait about another 15-20 minutes minutes after she ate her candy bar and drank her water, after which  she felt that she was able to leave safely.
pt exp pain upper lt back under scapula & lt rib cage, some nausea, felt a little feverish & both arms feel like going to sleep;
5/7/11 - blood pressure 122/74, pulse 80. 5/10/11 - received ZOSTAVAX vaccine. 5/11/11 - Nothing!! 5/12/11 - Woke up at 6:00 a.m. and had a red, hard, 3" diameter welt at injection site. 8:00 a.m. - tongue started to swell, face felt numb. 8:10 a.m. - felt blood pressure rising and pulse becoming very rapid. Went to hospital. My blood pressure was 200/100 and my pulse was 150. They gave me BENADRYL for the swelling and it helped. After a while, my blood pressure and pulse came down. I was released in approximately 2 hours. One week later (5/19/11) I was still feeling awful and having blood pressure problems and saw a cardiologist. On 5/19/11 I had an EKG and Echocardiogram and on 5/20/11 I had blood work done and a Nuclear Medicine Cardiac Stress Test done. I am now on blood pressure medication and I feel that if I had not had the ZOSTAVAX vaccine I would not be on blood pressure medication at this point in my life.
Received 1st Moderna vaccine on 1/12, woke up feeling sluggish, headache, low back pain, slight nausea. Went to work, had to go home. She is a diabetic, and was also hospitalized in march she was dx with Covid and bilat pneumonia.
Pt reported feeling faint and nauseous to administering RN immediately after vaccination. Pt was still seated at vaxxing table. Pt vomited x 1 mod amt, x1 sm amt into basket provided by nurse. Her appearance was pale and she was visibly shaky and reported feeling weak. Pt did not lose consciousness and denied SOB. Pt was advised by nurse to stay seated w/ head down. An ice pack was applied to the back of pt's neck. Pt reported having similar syncopal episodes when she gets blood drawn. She was transferred to wheelchair with assistance frm  administering nurse and on-site EMT team and moved to a quiet observation area. Pt was observed for 30 min while on continuous VS monitoring - all were stable and WNL. Pt's color returned and she stopped shaking w/in 10 min. Pt drank some water and had a hard candy. After 30 min pt reported feeling "fine", was up and ambulatory, alert and oriented, and stated she felt fine to drive home. Charge nurse and EMTs felt comfortable that pt was back to baseline and able to drive herself. Pt was advised to seek emergent care if sx returned/worsened, if she experienced any s/s of anaphylaxis or for any other concerning sx.
This spontaneous report as received from a registered nurse refers to a patient of unknown gender aged between 12 months old who on 16-JUL-2014, the patient was vaccinated at the same time with PROQUAD (Merck) (Lot # K007155 expiration date 12-NOV-2015) (dose not provided), subcutaneous and VARIVAX (Merck) (Lot # J014129 expiration date 07-NOV-2015) (dose and route not provided) at the same office visit. No adverse effects reported. No further information is available at this time. This is one of several reports from the same source. Additional information has been requested.
p/vax pt broke out w/rash followed by red bumps on arms; legs; & 1-2 on body progressing to blisters then scabs
High fever, dizziness, weakness, sore joints, headache, diarrhea.  Started approx. 8 hours after injection, worsened over the night, lasted into the next day.
Approx. 5 minutes after receiving the shot in my right upper arm, my right hand and fingers felt like they were asleep - numbness & tingling.  I had use of the hand but it felt like something was blocking the sense of touch and fine motor skills - touching fingertips to fingertips, were impaired.  Situation lasted for about 24 hours before appearing to resolve.  Sense of touch in fingertips still a little odd but hand is fully functional at this time.  Thank you.
Violent chills; malaise; nausea; vomited; diarrhea; skin sensitive to touch; weakness